Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation

ClinicalTrials.gov ID: NCT00755781

Public ClinicalTrials.gov record NCT00755781. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 2:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Controlled Study to Demonstrate the Efficacy and Safety of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation

Study identification

NCT ID: NCT00755781
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: APT Pharmaceuticals, Inc.; Industry
Enrollment: 284 participants

Conditions and interventions

Conditions

Lung Transplant

Interventions

Cyclosporine Inhalation Solution (CIS) Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2008
Primary completion: Aug 31, 2011
Completion: Oct 31, 2011
Last update posted: Sep 16, 2012

2008 – 2011

United States locations

U.S. sites: 18
U.S. states: 12
U.S. cities: 18

Facility	City	State	ZIP	Site status
UCLA School of Medicine	Los Angeles	California	90095	—
University of California, San Francisco	San Francisco	California	94143	—
Stanford University Medical Center	Stanford	California	94305	—
University of Colorado Health Sciences Center	Denver	Colorado	80262	—
University of Florida Health Sciences Center	Gainesville	Florida	32610	—
Mayo Clinic	Jacksonville	Florida	32224	—
Tampa General Hospital	Tampa	Florida	33601	—
University of Chicago Hospitals	Chicago	Illinois	60637	—
Loyola University Hospital	Maywood	Illinois	60153	—
Indiana Methodist Research Institute	Indianapolis	Indiana	46202	—
University of Maryland	Baltimore	Maryland	21201	—
University of Minnesota	Minneapolis	Minnesota	55455	—
New York Presbyterian Hospital, Columbia University Med. Ctr.	New York	New York	10032	—
Cleveland Clinic	Cleveland	Ohio	44195	—
Hospital of the University of Pennsylvania	Philadelphia	Pennsylvania	19104	—
University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15213	—
Baylor College of Medicine	Houston	Texas	77030	—
Inova Fairfax Hospital	Falls Church	Virginia	22402	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00755781, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 16, 2012 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00755781 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →